keytruda

Brand Visibility Tracking

How this brand shows up in AI chatbot answers — presence, position, sentiment, and how it stacks up against competitors.

Last checked: Aug 21, 2026
Score / 100
Latest check

Weighted composite of presence, position, sentiment, and recommendation strength across tracked prompts.

Presence
Avg. position
Lower is better
Sentiment
Recommendation mix — latest check

How the brand was framed across the latest tracked prompts.

Competitive landscape — latest check

Visibility vs. sentiment. Bubble size reflects rank position (bigger = higher-ranked).

Best known for — latest check
Head-to-head evidence exists in some situations
Both are PD-1 inhibitors.
Go-to agent for that indication/biomarker combination.
Core Claims — latest check
Keytruda is the brand name for pembrolizumab.
There is not an interchangeable generic 'pembrolizumab' in the usual small-molecule sense, because it’s a biologic monoclonal antibody.
Keytruda = pembrolizumab.
Indications overlap but are not identical.
Efficacy is often 'comparable' but not always equivalent.
Differentiators — latest check
Different antibodies (Keytruda is pembrolizumab; Opdivo is nivolumab).
Dosing schedules differ and indications differ by cancer type.
Combination regimens differ: Keytruda is commonly used in combinations; Opdivo is also used in combinations.
No universal generic; biosimilars may exist depending on location.
Efficacy is broadly similar but cancer-specific.
Competitor comparison — latest check
BrandVisibilitySentimentPositionRecommended

30-day composite trends

Score

Overall composite score, per day.

Visibility vs. sentiment

Two lenses on the same conversations — how much the brand shows up, and how it's spoken about.

Average rank position

Where the brand lands among all brands mentioned, in reading order. Lower is better.

Recent checks
DateScoreVisibilityPositionSentiment
Aug 12, 202658 66153
Aug 14, 202666 68155
Aug 15, 202662 62152
Aug 16, 202658 67154
Aug 17, 202659 68153
Aug 18, 202666 68150
Aug 19, 202662 68157
Aug 20, 202660 72150
Aug 21, 202651 63158